Related Experiment Video

Updated: Aug 18, 2026

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs
06:58

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs

Published on: May 18, 2022

Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference

S M Cashman1, E A Binkley, R Kumar-Singh

  • 1Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, Utah 84112-5330, USA.

Gene Therapy
|May 7, 2005
PubMed

Insights

This study demonstrates a novel RNA interference (RNAi) approach using short hairpin RNAs (shRNAs) to effectively silence rhodopsin alleles. This method offers a promising mutation-independent therapy for various inherited retinal degenerations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Ophthalmology

Background:

  • Over 100 mutations in the rhodopsin gene cause retinal degenerations like retinitis pigmentosa.
  • Developing mutation-independent therapies is crucial due to this genetic heterogeneity.

Purpose of the Study:

  • To develop and validate a mutation-independent therapeutic strategy for rhodopsin-associated retinal diseases using RNA interference (RNAi).

Main Methods:

  • Engineered short hairpin RNAs (shRNAs) from DNA templates to silence human rhodopsin alleles.
  • Utilized codon-exchanged mRNA (cmRNA) to confer resistance to shRNA-mediated silencing.
  • Simulated autosomal dominant retinitis pigmentosa in cell culture via triple DNA transfection.

Main Results:

  • Achieved significant silencing of both normal and mutant (P23H) human rhodopsin alleles (94.34% and 94.9%, respectively).
  • Demonstrated specific silencing of P23H rhodopsin (90.64%) without affecting translation from the resistant cmRNA.
  • Identified two alternative shRNA sequences targeting human rhodopsin.

Conclusions:

  • RNA interference offers a viable mutation-independent therapeutic approach for a wide spectrum of rhodopsin-related retinal degenerations.
  • The developed shRNA and cmRNA system effectively targets mutant rhodopsin while preserving normal protein production.

More Related Videos

Rearing and Double-stranded RNA-mediated Gene Knockdown in the Hide Beetle, Dermestes maculatus09:57

Rearing and Double-stranded RNA-mediated Gene Knockdown in the Hide Beetle, Dermestes maculatus

Published on: December 28, 2016

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...